Post by Johnson & Johnson | Vision

Breaking news: the TECNIS PureSee™ IOL is expanding to reach more practices across the U.S. following its recent FDA approval! Nearly 25 million Americans aged 40+ live with cataracts that make everyday tasks more challenging, yet cataract surgery is a very successful surgery.[1] With the full U.S. availability of TECNIS PureSee™ IOL, we are expanding access to an important extended depth of focus option that reflects our commitment to innovation, visual quality, and patient satisfaction.[2] To help support more informed discussions, we’ve developed a tool designed to guide conversations with your patients about which IOL options may be right for them: https://lnkd.in/e_scfw8g Read more about the full market release: https://lnkd.in/d48umBdi For Important Safety Information: https://lnkd.in/ezfK4ucY 1. Cataract Surgery Statistics in US 2026 | Costs, Success Rates & Key Facts. https://lnkd.in/djxKdmis May 24, 2026. 2. TECNIS PureSee™ IOL, Model DEN00V, DFU US, Z312075E rev B.